Replies to post #14033 on BioCurex, Inc.(fka BOCX)

[xkzuma]

Not necessarily at all. If a patient's blood test were to come back positive, RECAF has raised an important flag that further testing is warranted. Take prostate issues for example, an area I'm unfortunately all too aware of. The PSA and Free PSA tests are notoriously poor indicators of whether a person has cancer or not. If a person has had an elevated PSA, then tests positive with RECAF, there's a much higher likelihood that person does have prostate cancer. THEN
on to a prostate biopsy, which ain't foolproof either. Point is, cancer is oftentimes real sneaky and subtle. RECAF, in conjunction with thoroughly evaluating a person's family history of disease, can be a huge leg up for a doctor trying to diagnose where a possible cancer may be residing. There ain't likely ever going to be a true silver bullet out there for 100% cancer detection, but a RECAF blood test that has been proven reliable in general cancer detection could be a tremendous advantage to the medical community for screening and possible treatment purposes.

[i_invest_utrade]

TUMOR IMAGING Once cancer has been diagnosed, it is crucial to determine its location and size. Because the RECAF™ technology effectively detects cancer cells, cancer tissue can be targeted with special compounds administered to the patient. Since only cancer cells are selected, tumor locations can then be imaged using standard equipment.

http://biocurex.com/index3.html